Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A congenital mesoblastic nephroma characterized by increased cellularity, sheet-like proliferation of fibroblastic cells, and increased mitotic activity. Necrotic changes are commonly present.
Biomarker and diagnostic research for cellular congenital mesoblastic nephroma has been reported in the published literature.
1 clinical trial registered.
7 publications have been identified in PubMed for cellular congenital mesoblastic nephroma. Research spans Diagnostic / Biomarker (29%), Review / Meta-Analysis (29%), and Case Report / Case Series (29%).
Papke DJ (2025). [PMID: 39890305](https://pubmed.ncbi.nlm.nih.gov/39890305/). *Surgical pathology clinics*. [Review / Meta-Analysis]
Rullo E (2025). [PMID: 40178433](https://pubmed.ncbi.nlm.nih.gov/40178433/). *Genes, chromosomes & cancer*. [Case Report / Case Series]
Li J (2025). [PMID: 40947791](https://pubmed.ncbi.nlm.nih.gov/40947791/). *Pediatric blood & cancer*. [Review / Meta-Analysis]
Rubrecht A (2024). [PMID: 39275790](https://pubmed.ncbi.nlm.nih.gov/39275790/). *Histopathology*. [Case Report / Case Series]
Alpakra M (2024). [PMID: 39493139](https://pubmed.ncbi.nlm.nih.gov/39493139/). *Cureus*. [Gene Therapy / Novel Therapeutics]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:58 PM UTC
van der Beek JN (2024). [PMID: 38609702](https://pubmed.ncbi.nlm.nih.gov/38609702/). *Pediatric radiology*. [Diagnostic / Biomarker]